Screener
Summit Therapeutics SMMT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $14.7B.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's market capitalization?
- Summit Therapeutics (SMMT) reported market capitalization of $14.7B in Q1 2026.
- How has Summit Therapeutics's market capitalization changed year-over-year?
- Summit Therapeutics's market capitalization increased by 3.3% year-over-year, from $14.23B to $14.7B.
- What is the long-term trend for Summit Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Summit Therapeutics's market capitalization has grown at a 31.6% compound annual growth rate (CAGR), from $3.3B to $13.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Summit Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude